Mivacurium

DRUG4 trials

Sponsors

University of California, San Francisco, Dr. Horst Schmidt Klinik GmbH, Jakob Louis Thomsen, Matias Vested

Conditions

Intubating ConditionsMuscle RelaxationNeuromuscular BlockadeOnset Time of Mivacurium, Duration of Action of MivacuriumPerformance With Respiratory Exercise DevicePostoperative MyalgiaSex

Phase 1

Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium

CompletedNCT01906528

University of California, San FranciscoMuscle Relaxation, Sex

Start: 2013-03-31End: 2013-07-31Updated: 2014-04-11

Unknown Phase

Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy

CompletedNCT01966484

Dr. Horst Schmidt Klinik GmbHIntubating Conditions, Performance With Respiratory Exercise Device, Postoperative Myalgia

Start: 2013-10-31Target: 100Updated: 2014-07-30

Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals

CompletedNCT02914119

Jakob Louis ThomsenNeuromuscular Blockade

Start: 2016-10-01End: 2017-06-01Updated: 2019-09-12

Mivacurium 0.2 mg/kg in Young (18 - 40 Years) and Elderly (= 80 Years) Patients

CompletedNCT05558137

Matias VestedOnset Time of Mivacurium, Duration of Action of Mivacurium

Start: 2022-09-30End: 2023-05-25Updated: 2023-11-07

Related Papers

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade With E-Learning: Protocol for the Multicenter Interrupted Time Series INVERT Study

JMIR Research Protocols2017-10-065 citations